FENC (Fennec Pharmaceuticals) FFO per Share


FENC Fennec Pharmaceuticals Inc FENC
54 GF Score
Price $10.75
GF Value $10.09
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Fennec Pharmaceuticals FFO per Share?

FFO per Share only applies to REITs.

FENC
54GF Score
Fennec Pharmaceuticals Inc FENC
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fennec Pharmaceuticals (FENC) Overvalued in 2026?

Based on GuruFocus' analysis, Fennec Pharmaceuticals stock appears to be overvalued. The current stock price of $10.75 is trading 6.5% above its estimated GF Value™ of $10.09. GuruFocus considers Fennec Pharmaceuticals to be Fairly Valued.

Key valuation signals for FENC:

  • FFO per Share:
  • GF Value™: $10.09 vs. price of $10.75 (6.5% above fair value)
  • GF Score™: 54/100 with 2 warning signs

No single metric tells the full story. See the FENC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fennec Pharmaceuticals Business Description

Other Exchanges RV41:GermanyFRX:Canada
Address 68 TW Alexander Drive, PO Box 13628, Research Triangle Park, NC, USA, 27709
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
54GF Score

Get the complete analysis for FENC

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.75
Price
$10.09
GF Value